Connect Biopharma Holdings Limited

NASDAQ:CNTB

Biotechnology

Healthcare
$0.80 -4.09%

-$0.09 today

Market cap
$50.52M
Beta
-0.21
P/E (TTM)
-4.0
EPS (TTM)
-$0.50
52W Low $0.91High $3.82

Volume 2.50M

Average 0.30M

Returns on capital

Connect Biopharma Holdings Limited management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-132.2%

avg 66.6%

ROIC

-135.7%

avg -85.6%

ROA

-98.9%

avg -135.8%

Analysis

ROA is currently the strongest return metric at -98.9% versus its period average of -135.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Barry D. Quart

Chief Executive Officer & DirectorUSD 980.22K690<0.01%

David L. Szekeres

PresidentUSD 734.97K52——

Lisa Peraza

Senior Vice President of FinanceUSD 571.13K490<0.01%

Jeff Cohn

General Counsel & Corporate Secretary—44——

Lei Sun

Vice President of Biologics & Head of CMC—62——

Sean T. Ristine

Vice President of Human Resources—56——

Srikanth Pendyala

Senior Vice President of Clinical Development(Consultant)————

Kimberly J. Manhard

Executive Vice President & Chief Development Officer—66——

Compensation is shown in the reported currency; data updated Oct 3, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Mar 16, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

2

$4.37M

Sells

0

$0.00

Net Transaction Value

+$4.37M

Net buying

Most Active

Huang James

2 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
May 29, 26

Huang James

Indirect

Buy$371.6K
Mar 31, 26

Huang James

Indirect

Buy$4M

Summary

Insiders reported 2 buys worth $4.37M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $4.37M. Huang James was the most active insider with 2 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
+300.6% (5yr)3 analysts
Net IncomeN/AN/AN/A
N/A3 analysts
EBITN/AN/AN/A
N/A3 analysts

Analysis

Forward estimates point to Revenue at +300.6% (5yr), giving you a quick read on expected growth from here.

Competitors

Who does Connect Biopharma Holdings Limited compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about CNTB's management, answered from reported figures.

Who manages CNTB?

Connect Biopharma Holdings Limited (CNTB) lists 8 active executives. The top listed executive is Barry D. Quart, Chief Executive Officer & Director.

Are CNTB insiders buying or selling?

Recent insider activity shows net buying of $4.37M.